1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 20 JULY 2015

Key Pharma News 20 JULY 2015

  • July 2015
  • -
  • Espicom Business Intelligence
  • -
  • 30 pages

Industry Trend Analysis - Horizon Will Need To Raise Offer For Depomed
Industry Brief - Allergan To Acquire Worldwide Rights To Merck's CGRP Migraine Development Programme
Industry Brief - Lilly/SDP Sign Sales Collaboration Agreement For Trulicity In Japan
Industry Trend Analysis - J&J To Remain Committed To HCV
Industry Brief - Biogen Plans New Production Plant In Switzerland
Industry Brief - Baxalta Launched To Deliver Therapies For Orphan Diseases And Underserved Conditions
Industry Trend Analysis - Receptos Acquisition Will Enhance Celgene's Blockbuster Autoimmune Expectations
Industry Brief - Sanofi To Reorganise Business Structure
Industry Trend Analysis - Newly Approved Rexulti Will Need To Be Differentiated From Predecessor Abilify
Industry Trend Analysis - Cobimetinib/Zelboraf Combination Will Gain Delayed FDA Approval
Industry Brief - FDA Approves Novartis' New Heart Failure Medicine Entresto
Industry Brief - Spiolto Respimat Approved In First European Countries
Industry Brief - FDA Approves Orkambi For CF
Industry Brief - EC Approves Vanda's Hetlioz For Non-24
Industry Brief - Sanofi's Lantus XR Approved In Japan
Industry Brief - EU Approval Sought For Arzerra As Maintenance Therapy For Relapsed CLL
Industry Trend Analysis - FDA's Expectations Indicate A Rapidly-Emerging Biosimilar Market Ahead
Industry Brief - Imbruvica Gains EU Approval For WM
Industry Trend Analysis - Necitumumab Closes In On Approval
Industry Brief - Mylan Launches Bexarotene In US
Industry Trend Analysis - Path Opened For Chinese Generic Sofosbuvir But Impact On Gilead Will Be Muted
Industry Trend Analysis - Iressa's US Return Will Be Further Enhanced By Liquid Biopsy
Industry Trend Analysis - Actavis' Grip On Namenda Market To Diminish
Industry Trend Analysis - EMA's HPV Vaccine Safety Review Will Have Little Impact On Sales
Industry Brief - Teva Launches Almotriptan In US
Industry Trend Analysis - Remsima On Course To Be A Global Biosimilar
Industry Trend Analysis - Ixazomib Will Gain Swift Approval In US
Industry Brief - Hospira Gains Bivalirudin Approval; TMC Enters Authorised Generic Agreement With Sandoz
Industry Trend Analysis - Big Pharma Investment In Alzheimer's To Continue Despite Sembragiline's Failure
Industry Trend Analysis - Oncolytics Biotech Will Be Target For Immunotherapy Partnerships
Industry Trend Analysis - Array's BRAF Inhibitor Success Relies On Differentiation
Industry Brief - Novo Nordisk Successfully Completes First Phase IIIa Trial With Semaglutide
Industry Brief - Phase III Results Show LDL-C Reductions Of More Than 60% In Praluent-Treated Japanese Patients
Industry Trend Analysis - Atezolizumab Will Be Significant Anti-PD-1 Competitor In 2016

Table Of Contents

Key Pharma News 20 JULY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.